Looking beyond Wall Street's top-and-bottom-line estimate forecasts for Agilent (A), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended July 2026.

Agilent Technologies (NYSE:A | A Price Prediction) heads into a pivotal earnings setup for retirement-oriented portfolios, with a company-confirmed Q3 2026 report after the close on Aug.

Advisors Capital Management LLC purchased a new position in Agilent Technologies, Inc. (NYSE: A) in the undefined quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm purchased 62,474 shares of the medical research company's stock, valued at approximately $8,299,000. Several other large investors

Bank of New York Mellon Corp raised its position in shares of Agilent Technologies, Inc. (NYSE: A) by 87.4% during the undefined quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 5,233,964 shares of the medical research company's stock after purchasing an additional 2,440,360 shares

Investors looking for stocks in the Medical - Products sector might want to consider either Medtronic (MDT) or Agilent Technologies (A). But which of these two stocks presents investors with the better value opportunity right now?

BIP Wealth LLC acquired a new stake in shares of Agilent Technologies, Inc. (NYSE: A) in the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor acquired 6,277 shares of the medical research company's stock, valued at approximately $834,000. Several other institutional investors have also

Assenagon Asset Management S.A. trimmed its stake in Agilent Technologies, Inc. (NYSE: A) by 75.3% during the second quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 10,454 shares of the medical research company's stock after selling 31,934 shares during the quarter. Assenagon Asset Management S.A.'s

Agilent Technologies (NYSE: A - Get Free Report) and Many Bright Ideas Technologies (OTCMKTS:MBGNF - Get Free Report) are both healthcare companies, but which is the better business? We will compare the two companies based on the strength of their institutional ownership, profitability, analyst recommendations, valuation, earnings, risk and dividends. Analyst Recommendations This is a summary

Ashton Thomas Securities LLC grew its stake in shares of Agilent Technologies, Inc. (NYSE: A) by 47.1% in the undefined quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 19,956 shares of the medical research company's stock after acquiring an additional 6,387 shares during

SANTA CLARA, Calif.--(BUSINESS WIRE)--Agilent Technologies Inc. (NYSE: A) today announced that the Eastern Institute of Technology, Ningbo has received an Agilent Research Catalyst (ARC) Award on behalf of Professor Zongwei Cai. The award recognizes Professor Cai's innovative research focused on developing advanced analytical approaches for detecting per- and polyfluoroalkyl substances (PFAS) and other emerging contaminants, a growing area of importance for environmental and public health resea.